Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]

Uzoma N. Ibebuogu; Oluwaseyi Bolorunduro; Smith Giri; Sam Dagogo-Jack; Blake G. Smith; Saibal Kar; Guy L. Reed

doi:10.1007/s40256-015-0118-3

Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]

Uzoma N. Ibebuogu
, Oluwaseyi Bolorunduro
, Smith Giri
, Sam Dagogo-Jack
, Blake G. Smith
, Saibal Kar
, Guy L. Reed

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	287
Number of pages	1
Journal	American Journal of Cardiovascular Drugs
Volume	15
Issue number	4
DOIs	https://doi.org/10.1007/s40256-015-0118-3
State	Published - Aug 25 2015
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1007/s40256-015-0118-3

Cite this

Ibebuogu, U. N., Bolorunduro, O., Giri, S., Dagogo-Jack, S., Smith, B. G., Kar, S., & Reed, G. L. (2015). Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]. American Journal of Cardiovascular Drugs, 15(4), 287. https://doi.org/10.1007/s40256-015-0118-3

Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]. / Ibebuogu, Uzoma N.; Bolorunduro, Oluwaseyi; Giri, Smith et al.
In: American Journal of Cardiovascular Drugs, Vol. 15, No. 4, 25.08.2015, p. 287.

Research output: Contribution to journal › Comment/debate › peer-review

Ibebuogu, UN, Bolorunduro, O, Giri, S, Dagogo-Jack, S, Smith, BG, Kar, S & Reed, GL 2015, 'Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]', American Journal of Cardiovascular Drugs, vol. 15, no. 4, pp. 287. https://doi.org/10.1007/s40256-015-0118-3

Ibebuogu UN, Bolorunduro O, Giri S, Dagogo-Jack S, Smith BG, Kar S et al. Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]. American Journal of Cardiovascular Drugs. 2015 Aug 25;15(4):287. doi: 10.1007/s40256-015-0118-3

Ibebuogu, Uzoma N. ; Bolorunduro, Oluwaseyi ; Giri, Smith et al. / Erratum to : Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]. In: American Journal of Cardiovascular Drugs. 2015 ; Vol. 15, No. 4. pp. 287.

@article{134f4bc107b64a00b7284851dff46c5e,

title = "Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]",

author = "Ibebuogu, \{Uzoma N.\} and Oluwaseyi Bolorunduro and Smith Giri and Sam Dagogo-Jack and Smith, \{Blake G.\} and Saibal Kar and Reed, \{Guy L.\}",

year = "2015",

month = aug,

day = "25",

doi = "10.1007/s40256-015-0118-3",

language = "English (US)",

volume = "15",

pages = "287",

journal = "American Journal of Cardiovascular Drugs",

issn = "1175-3277",

publisher = "Adis",

number = "4",

}

TY - JOUR

T1 - Erratum to

T2 - Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]

AU - Ibebuogu, Uzoma N.

AU - Bolorunduro, Oluwaseyi

AU - Giri, Smith

AU - Dagogo-Jack, Sam

AU - Smith, Blake G.

AU - Kar, Saibal

AU - Reed, Guy L.

PY - 2015/8/25

Y1 - 2015/8/25

UR - https://www.scopus.com/pages/publications/84937967160

UR - https://www.scopus.com/pages/publications/84937967160#tab=citedBy

U2 - 10.1007/s40256-015-0118-3

DO - 10.1007/s40256-015-0118-3

M3 - Comment/debate

AN - SCOPUS:84937967160

SN - 1175-3277

VL - 15

SP - 287

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

IS - 4

ER -

Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [Am J Cardiovasc Drugs, 10.1007/s40256-015-0113-8]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this